xCures’ treatment options include, where applicable, therapies on the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. TAPUR is a clinical trial for patients with advanced cancer who have not responded to standard treatment or are without available standard treatment options and who have genomic alterations in their tumors that can be targeted with a commercially available anticancer drug.